PE4S157 - Endocrine Related Cancer 01 Sep 2019 - 31 Aug 2031 | Version 2

Associated Module Information

Module Code: PE4S157
Module Title: Endocrine Related Cancer
Faculty: Faculty of Life Sciences and Education
Faculty Group: Allied Health and Chiropractic
Faculty Sub Group: Clinical Services
Module Leader: Karl New
Module Team:
First Intended Intake: SEP 2017 Final Year of Intake: 2030
Date Closed:
Credit Value: 20 Credit Level: 7
Language: English
Percentage of Module Taught in Welsh: 0
Equivalent Module:
HECOS codes: 100260 - healthcare science
HECOS Code Weighting: 100

Document Version Information

Version 2
Valid From 01 Sep 2019
Valid To 31 Aug 2031

Module Aims

Conduct in-depth analysis of the presentation, investigation, diagnosis, and management of endocrine-related cancers, critically appraising current research to propose and justify innovative approaches to patient care and treatment.

Content Summary

Indicative content to include topics outlined below and/or any other relevant current topics to fulfil the module aims and learning outcomes:

Topics may include:

Thyroid cancer including follicular, medullary and anaplastic thyroid cancer

Epidemiology, understanding evidence based treatments

Principles of investigation and management.

Ablative radioiodine treatment

Surveillance of patients with thyroid cancer

Long term thyroid hormone replacement

Adrenal Cancer

Presentation, investigation and management

Adjunctive medical therapies

Basic principles of chemotherapies used in the treatment of adrenal cancer

Neuroendocrine Tumours (NETs)

Classification of NETs

Investigation of NETs including chromogranin and somatostatin scintigraphy

Management of NETs; somatostatin analogues

Carcinoid syndrome – presentation, investigation and treatment.

NETs in genetic conditions such as MEN

Learning and Teaching Methods

Activity Type Hours
Independent Study 80
Directed Study 40
Seminars 40
Problem/Challenge-based Learning 40
Total Hours Selected 200

Learning Outcomes

# Learning Outcome
LO1 Synthesise and critically appraise evidence relating to the diagnosis and management of patients with endocrine-related cancers, identifying gaps in current knowledge.
LO2 Develop and justify evidence-based recommendations for improving the investigation and management of patients with neuroendocrine tumours, grounded in critical analysis of current research.

Module Requisites

N/A

Assessment Criteria

Assessment Category Assessment Type Description Duration Word Count Weight (%) Best of? Pass Mark
Synchronous Online Assessment Time-constrained assessment (Online) 1 Assessment to be completed in a specific timescale, which is neither an invigilated examination nor a piece of coursework. To be completed over an extended period (e.g. a 2-hour task to be completed within 48 hours, or a 24-hour assessment). Learna: End of module 1-hour Case-based Multiple-choice Examination related to Endocrine-Related Cancer to be completed within a 10-day period. 60 N/A 30 No 40
Asynchronous Assessment Self Reflective Assessment 1 A personal record of a student’s learning experiences. It requires students to record and reflect upon their observations and responses to situations, which can then be used later to explore and analyse ways of thinking and being in context. Generally involves critical diaries, learning logs and written / visual journals. Learna: Reflective journal 0 600 10 No 40
Asynchronous Assessment Project 1 A detailed analysis of a topic, involving some original research undertaken by the candidate who makes use of data and/or primary sources. Learna: Completion of an individual/group task related to Endocrine-Related Cancer. 0 1000 20 No 40
Asynchronous Assessment Case study 1 A concentrated inquiry into a single case or subject. Learna: Case-based scenarios and a discussion forum related to Endocrine-Related Cancer. 0 2500 40 No 40

Assessment Matrix

Assessment Type Learning Outcomes
LO1 LO2
Time-constrained assessment (Online) 1
Self Reflective Assessment 1
Project 1
Case study 1

Reading List

The module reading list is available to the students to access via electronic links on the learning platform (Moodle).

In addition to the list below, each list is supplemented with up-to-date peer-reviewed journal articles and studies that are continually refreshed as guidelines change and new treatments and technologies emerge.

Additional reading resources are also provided where relevant by the tutors during the running of the module in the discussion forum to keep the reading resources current and relevant.

Indicative Module 6 Reading:

Clinical Endocrinology. [Online]

Endocrine-Related Cancer. [Online]

Endocrine Reviews. [Online]

European Neuroendocrine Tumor Society (no date) ENETS Guidelines & Standards of Care. [Online]

Lenders, J.W.M., Duh, Q.-Y., Eisenhofer, G., Gimenez-Roqueplo, A.-P., Grebe, S.K.G., Murad, M.H., Naruse, M., Pacak, K. and Young, W.F., Jr. (2014) 'Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline', The Journal of Clinical Endocrinology & Metabolism, 99(6), pp. 1915-1942.

Perros, P., Colley, S., Boelaert, K., Evans, C., Evans, R.M., Gerrard, G.E., Gilbert, J.A., Harrison, B., Johnson, S.J., Giles, T.E., Moss, L., Lewington, V., Newbold, K.L., Taylor, J., Thakker, R.V., Watkinson, J. and Williams, G.R. (2014) 'Guidelines for the management of thyroid cancer', Clinical Endocrinology, 81(Suppl. 1), pp. 1-122.

Sklar, C.A., Antal, Z., Chemaitilly, W., Cohen, L.E., Follin, C., Meacham, L.R. and Murad, M.H. (2018) 'Hypothalamic–Pituitary and Growth Disorders in Survivors of Childhood Cancer: An Endocrine Society Clinical Practice Guideline', The Journal of Clinical Endocrinology & Metabolism, 103(8), pp. 2761-2784.